In a world where biotech often feels like a high-stakes science fair with billion-dollar consequences, one startup from Vadodara is quietly rewriting the rules. Genexis Biotech, founded in 2019 by Vipul Kumar and Dr. Jitendra Wagh, is turning heads, and petri dishes, with its mission to make biotechnology ethical, sustainable, and animal-free.
And they’re not just talking the talk. With a fresh ₹4 crore seed round led by GVFL and Benzai10, Genexis is scaling up its precision fermentation game to deliver high-quality recombinant proteins without a single moo, oink, or cluck involved.
From Vadodara With Science: The Founders Behind the Fermentation
Let’s start with the brains behind the beakers.
Vipul Kumar, director and co-founder, is the business strategist who’s been steering Genexis through the maze of biotech innovation. He’s the kind of guy who can talk about protein purification and market expansion in the same breath and make both sound exciting.
Dr. Jitendra Wagh, co-founder and biotech veteran, brings the scientific firepower. With a PhD and years of experience in molecular biology, he’s the one making sure Genexis doesn’t just dream big, it delivers.
Together, they’ve built a company that’s not just about making proteins. It’s about making a point.
What Genexis Does (And Why It’s Cool)
Genexis Biotech is all about animal-origin-free recombinant proteins. Translation: They make proteins that are usually sourced from animals, like transferrin, albumin, and growth factors, using precision fermentation instead.
This means:
- No animal cruelty
- No contamination risks
- No ethical dilemmas
- Just clean, scalable science
Their product lineup includes
- Cytokines and specialty proteins
- Cell culture media and reagents
- Viral transport media (VTM)
- Cell detachment solutions
- Recombinant peptidases like aminopeptidase and enterokinase
And yes, they’re working on encapsulated growth factors for cosmetics. Because who said biotech can’t be bougie?
Why Precision Fermentation Is the Beyoncé of Biotech
Precision fermentation is having a moment. It’s the process of using engineered microbes to produce complex molecules, like proteins, without needing animals or traditional farming.
Genexis is using this tech to:
- Replace fetal bovine serum (FBS) in cell culture.
- Create sustainable alternatives for pharma and food tech.
- Support regenerative medicine and cellular agriculture.
- Make biotech exports that don’t raise eyebrows at customs.
It’s clean, scalable, and future-proof. It’s the Tesla of protein production.
The Facility That’s Cleaner Than Your Kitchen
Genexis operates a Class 10,000 certified facility, which means it’s cleaner than most operating rooms. They’re also building a GMP-compliant unit to meet global standards for pharmaceutical manufacturing.
This isn’t a garage startup. It’s a full-blown biomanufacturing setup with:
- Bioreactors ready to scale
- Downstream processing infrastructure
- Quality control systems that would make your high school lab teacher weep with joy
And yes, they’ve already received multiple orders for alternative protein formulations. The demand is real.
The Funding That’s Fueling the Fermentation
In July 2025, Genexis Biotech raised ₹4 crore in seed funding. The round was led by GVFL, one of India’s OG venture capital firms, with participation from Benzai10, an agriculture-focused investment fund.
The money is being used to:
- Expand bioreactor capacity.
- Build downstream processing infrastructure.
- Launch new recombinant proteins and enzymes.
- Strengthen regulatory compliance.
- Scale distribution networks.
They’re going from startup to scale-up faster than you can say “recombinant albumin.”
Partnerships, MoUs, and Bio-India Fame
Genexis isn’t just building in isolation. They’ve:
- Partnered with pharmaceutical and biotech firms
- Signed an MoU with the Gujarat government to scale recombinant protein manufacturing
- Showcased their innovations at Global Bio-India 2024
- Collaborated with CDMOs, academic labs, and biopharma players
They’re not just making proteins. They’re making moves.
The Mission That’s More Than Just Molecules
Genexis Biotech’s mission is simple but powerful:
“To create ethical, sustainable solutions that fuel the next generation of scientific innovation.”
They’re replacing animal-based products with scalable, cruelty-free alternatives. And they’re doing it with precision, passion, and a whole lot of petri dishes.
Their vision? A world where biotech powers sustainable agriculture, ethical pharmaceuticals, and innovative biopharma.
And honestly, we’re here for it.
Why Genexis Is the Startup to Watch
Let’s recap why Genexis is low-key iconic:
✅ Founded by legit biotech brains
✅ Focused on cruelty-free, scalable solutions
✅ Backed by serious investors
✅ Operating a certified clean facility
✅ Already making waves in pharma and cosmetics
✅ Building India’s deep-tech backbone for ethical biomanufacturin
They’re not just riding the biotech wave. They’re shaping it.
Final Thoughts: Genexis Is Fermenting a Better Future
In a world where science often feels detached from ethics, Genexis Biotech is proving that you can have both. They’re building proteins without animals, scaling without shortcuts, and innovating without compromise.
From Vadodara to the world, Genexis is showing that biotech can be clean, green, and genuinely transformative.
So next time someone says biotech is boring, hand them a Genexis growth factor and say, “This came from a fermenter, not a farm.”
And watch their jaws drop.
